BSECompany UpdateM&A1h ago
Emcure Pharmaceuticals Ltd
Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited
Emcure Pharmaceuticals Ltd has completed the acquisition of 12.05% of Gennova Biopharmaceuticals Ltd's shares, making Gennova a wholly-owned subsidiary. The acquisition was completed on July 21, 2026, for an aggregate consideration of Rs. 2,318.7 Million.
BSECompany UpdateM&A1h ago
Mercantile Ventures Ltd
Intimation of Hon''ble NCLT Order sanctioning the Scheme of Amalgamation of M/s. Walery Security Management Limited (Transferor Company), a subsidiary of the Company with M/s. i3 Security ....
Mercantile Ventures Ltd has announced that the Hon'ble National Company Law Tribunal has approved the Scheme of Amalgamation between Walery Security Management Limited and i3 Security Private Limited, both subsidiaries of the Company. The amalgamation is an internal reorganization of the subsidiary structure and does not involve any change in the shareholding pattern of the listed company.
BSECompany Update▲ PositiveM&A1h ago
Sona BLW Precision Forgings Ltd
Press Release - SONA Comstar partners with DENSO Corporation, Japan.
Sona BLW Precision Forgings Ltd has partnered with DENSO Corporation, Japan to establish two joint ventures for developing and manufacturing advanced electric and hybrid powertrain systems.
BSEBoard MeetingM&A1h ago
SAB Events & Governance Now Media Ltd
SAB Events & Governance Now Media Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve Implementation ....
SAB Events & Governance Now Media Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 25/07/2026 to consider and approve the implementation of the matters under the Resolution Plan approved by Hon'ble NCLT vide its Order dated July 10, 2026.
BSEOthersM&A1h ago
Sona BLW Precision Forgings Ltd
Outcome of Board Meeting and intimation under Reg 30 of SEBI (LODR) Regulations, 2015
Sona BLW Precision Forgings Ltd has approved the transfer of its Electric Vehicle business to Sona Comstar eDrive Private Ltd on a going concern basis for INR 8,932 million, and entered into a joint venture with DENSO Corporation for the development of electric and hybrid powertrain systems.
BSEInsider Trading / SASTM&A1h ago
Uniphos Enterprises Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Demuric Holdings Pvt Ltd & PACs
Demuric Holdings Private Limited has acquired 73.28% of Uniphos Enterprises Ltd's shares through a scheme of amalgamation, increasing its stake in the company.
BSECompany UpdateM&A2h ago
Siyaram Silk Mills Ltd-$
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 in realtion to approval of the Scheme of Arrangement between Siyaram Silk Mills ....
Siyaram Silk Mills Ltd has received approval from the National Company Law Tribunal for its Scheme of Arrangement, which involves the issuance of Preference Shares by way of bonus to its shareholders. The Scheme was approved unanimously by the Board of Directors and was also approved by the equity shareholders and unsecured creditors of the Company. The Tribunal has sanctioned the Scheme under Section 230 of the Companies Act, 2013.
BSECompany Update▲ PositiveM&A2h ago
Tejassvi Aaharam Ltd
Updates on acquisition of shares of Funk Foods Private Limited is enclosed herewith
Tejassvi Aaharam Ltd has announced the acquisition of 100% equity stake of Funk Foods Private Limited through a share swap deal. The acquisition will strengthen the company's position in the food products market. The company has allotted 5,11,62,204 equity shares at an issue price of Rs. 10 each, amounting to Rs. 51,16,22,040 on swap basis.
BSECompany UpdateM&A5h ago
Parmax Pharma Ltd
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
Parmax Pharma Ltd has received a letter of offer from Fedex Securities Pvt Ltd, the manager to the offer, for the acquisition of up to 23,46,250 equity shares, representing 26% of the expanded voting capital, by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with 10 persons acting in concert, at a price of ₹42.80 per equity share.